ADNEX and SRrisk model as second steps were estimated, using area under the receiver operating characteristic curves (AUCs). The performances of the two-step strategies were expressed as sensitivity at 80% specificity. Single imputation was used to deal with missing CA125 values. Results: Revised benign EDs were not applicable in 1878/2368 masses (79%). In these tumours, the ADNEX model with CA125 showed the best diagnostic accuracy in terms of AUC (0.903), followed by SRrisk model (0.887), ADNEX without CA125 (0.884), and RMI (0.834).
ADNEX and SRrisk model as second steps were estimated, using area under the receiver operating characteristic curves (AUCs). The performances of the two-step strategies were expressed as sensitivity at 80% specificity. Single imputation was used to deal with missing CA125 values. Results: Revised benign EDs were not applicable in 1878/2368 masses (79%). In these tumours, the ADNEX model with CA125 showed the best diagnostic accuracy in terms of AUC (0.903), followed by SRrisk model (0.887), ADNEX without CA125 (0.884), and RMI (0.834).
At a fixed specificity of 80%, the two-step strategies starting with the revised benign EDs followed by SRrisk, ADNEX without CA125 and ADNEX with CA125 had sensitivities ranging from 90% to 92%, compared to 82% for benign EDs followed by RMI.
Conclusions:
In adnexal masses where the revised IOTA benign EDs cannot be applied, second steps involving IOTA ADNEX or SRrisk models have superior discriminative ability compared to RMI. 
Gynecology, University Hospital Southampton, Winchester, United Kingdom
Objectives: Accurate prediction of malignancy in adnexal masses is important for planning the appropriate surgical procedure.
The aim of our study was to compare the performance of different IOTA ultrasound-based risk of malignancy indicators and to compare management strategies in the pre-operative diagnosis of adnexal masses. Methods: Between 1/5/2012 and 31/08/2016 ultrasound data from patients with an adnexal mass was collected prospectively by two IOTA-accredited examiners.
Inclusion criteria were: transvaginal ultrasound, available histological diagnosis within 120 days of the initial scan. Pregnant patients were excluded.
All patients had a minimum of 6 months' follow-up. Subjective Impression (SI), RMI, Simple Rules (SR), LR2 and ADNEX were recorded for each patient. Results: We recorded data on 956 patients, of whom 316 were eligible for the study.
• 128 patients (41%) had malignant tumours.
• Subjective Impression was Inconclusive in 19 patients (6%).
• RMI was not available in 18 patients (5.7%) • Simple Rules were Inconclusive in 114 patients (36%) • LR2 was available in all 316 patients (100%)
• ADNEX was available in 143 patients (45%) • See supporting information online for summary of results.
The test with the highest sensitivity (97%) was ADNEX with a cut-off at 10%.
Combining indicators could improve specificity, which is underestimated in this analysis by exclusion of patients who had surgery later than 120 days, for whom longer follow-up is needed. Conclusions: IOTA Risk of Malignancy Indicators are superior to RMI in the prediction of malignancy in adnexal masses. A combination strategy is equivalent to Subjective Impression by an experienced examiner.
Supporting information can be found in the online version of this abstract Objectives: Our group has showed that the postnatal outcome of fetuses diagnosed with pulmonary atresia-critical stenosis with intact ventricular septum (PA-CS/IVS) may be accurately established with a combination of four echocardiographic parameters 1 . The objective of this study is to validate the utility for predicting the postnatal outcome of fetuses with PA-CS/IV by this score. Methods: Observational study of prospective cohorts undertaken at a tertiary centre of fetuses with PA/CS-IVS between January 2010-June 2016. We used the cut-off points of our score (tricuspid valve/mitral valve ratio ≤0.83, pulmonary valve/aortic valve ratio ≤0.75, right ventricle length/left ventricle length ratio ≤0.64, and tricuspid inflow duration/cardiac cycle length ≤36.5%). We included 3 patients underwent prenatal pulmonary valvuloplasty (PPV) in order to determine the discriminatory capacity of these cases with the score. We divided the score into three subgroups: ≤ 1 parameter (high probability of BVC), 2 (PPV candidates) and ≥ 3 (high probability of non-BVC). We evaluated the predictive capability of the score for these three prognosis situations. Results: The study group included 29 liveborn fetuses (22 with BVC and 7 with non-BVC). The presence of ≤ 1 parameter of the score allowed to predict a BVC with a sensitivity (Sn) of 74% (CI 95, 51-88%) and a specificity (E) of 80% (CI 95%, 49-94%). If ≥ 3 markers were presented a non-BVC were predicted with a Sn of 43% (CI 95%, 16-75%) and a E of 91% (CI 95%, 72-98%). Finally, cases candidates for PPV could be predicted in those with two parameters with a Sn of 100% (CI 95%, 44-100%) and a E of 81% (CI 95%, 62-92%).
Conclusions:
The postnatal outcome of PA/CS-IVS fetuses can be predicted with good precision by means of a score based on 4 echocardiographic parameters that are easy to explore. This score also allows us to select cases candidates for fetal therapy. London, London, United Kingdom; 2 Pediatric Cardiology and Brompton Centre for Fetal Cardiology, Royal Brompton and Harefield Hospitals NHS Foundation Trust, London, United Kingdom; 3 Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, London, United Kingdom Objectives: To evaluate perinatal and perioperative changes in ventricular geometry, myocardial performance and cardiac function in term fetuses with simple transposition of the great arteries (TGA). Methods: Prospective longitudinal study of 67 women delivering at term including 54 pregnancies with normal outcome and 13 pregnancies affected by fetal transposition of the great arteries. B-mode, M-mode, pulsed wave Doppler, spectral tissue Doppler and speckle tracking imaging echoes were performed few days before delivery and within hours of birth. Postoperative echo assessment was conducted 10 days after the arterial switch operation (ASO). Results: Comparison of normal fetal and neonatal groups to TGA fetuses and neonates (before ASO) showed a significant (p<0.001) alteration in ventricular geometry (RV sphericity index: fetus 1.8 vs. 1.6; neonate 2.3 vs. 1.7), myocardial deformation (LV torsion: fetus 2.1deg/cm vs. 3.0deg/cm; neonate: 1.3deg/cm vs. 1.7deg/cm), and cardiac function (LV cardiac output [CO] : fetus 197ml/min/kg vs. 319ml/min/kg; neonate: 269ml/min/kg vs. 356ml/min/kg), respectively. Perinatal and perioperative changes within TGA group (fetus vs. neonate before ASO vs. neonate after ASO) showed a significant (p<0.001) alterations in cardiac geometry (RV sphericity index: 1.6 vs. 1.7 vs. 2.0), myocardial deformation (LV torsion: 3.0deg/cm vs. 1.7deg/cm vs. 0.0deg/cm), and cardiac function (combined CO: 582ml/min/kg vs. 809ml/min/kg vs. 611ml/min/kg; RV myocardial longitudinal systolic velocities S': 6.7cm/s vs. 9.3cm/s vs. 4.1cm/s; RV diastolic E/E': 6.5 vs. 7.3 vs. 14.7), respectively. Conclusions: Altered perinatal cardiac parameters in TGA infants suggest that the deleterious impact of hypoxemia on myocardial performance is already evident in utero with significant worsening of the effects after birth. The alteration of cardiac indices after corrective surgery could be due to the acute changes in loading conditions with establishment of serial cardiovascular circulation and as a consequence of preoperative neonatal hypoxemia.
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